These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7164039)

  • 21. [Subacute myelo-optic neuritis].
    Vanĕcek J; Fink Z
    Cesk Pediatr; 1979 Nov; 34(11):661-2. PubMed ID: 160840
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental myelo-optico-neuropathy induced by ethambutol].
    Tateishi J; Kuroda S; Otsuki S
    Rinsho Shinkeigaku; 1974 Jul; 14(7):559-67. PubMed ID: 4473301
    [No Abstract]   [Full Text] [Related]  

  • 23. Subacute myelo-optic neuropathy in Australia.
    Selby G
    Lancet; 1972 Jan; 1(7742):123-5. PubMed ID: 4108984
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prognosis and rehabilitation in subacute myelo-optico-neuropathy with abdominal symptoms].
    Sugiyama T; Hanakago R
    Saishin Igaku; 1969 Dec; 24(12):2510-8. PubMed ID: 5363409
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical features of SMON.
    Toyokura Y; Takasu T
    Jpn J Med Sci Biol; 1975; 28 Suppl():87-99. PubMed ID: 136544
    [No Abstract]   [Full Text] [Related]  

  • 26. Subacute myelo-optico-neuropathy (S.M.O.N.) in Japan. A community survey.
    Nakae K; Yamamoto S; Igata A
    Lancet; 1971 Sep; 2(7723):510-2. PubMed ID: 4105662
    [No Abstract]   [Full Text] [Related]  

  • 27. Subacute myelo-optico-neuropathy (SMON).
    Nelson E
    Ann Intern Med; 1972 Sep; 77(3):468-70. PubMed ID: 4262315
    [No Abstract]   [Full Text] [Related]  

  • 28. [Subacute myelo-optic-neuropathy during treatment with chloro-iodo-hydroxyquinoleine (author's transl)].
    Charasz N; Vacherot B; Dougados M; Bousser MG; Belaiche J; Cattan D
    Gastroenterol Clin Biol; 1979 Apr; 3(4):371-4. PubMed ID: 159200
    [No Abstract]   [Full Text] [Related]  

  • 29. [6 cases of so-called subacute myelo-optico-neuropathy with abdominal symptoms in a ward of a tuberculosis sanatorium].
    Nakamura Y; Ogata J; Watanabe T; Kumagai T
    Shinkei Kenkyu No Shimpo; 1971; 15(4):1019-31. PubMed ID: 5168624
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuropathology of subacute myelo-optico-neuropathy, "SMON".
    Shiraki H
    Jpn J Med Sci Biol; 1971 Aug; 24(4):217-43. PubMed ID: 5316312
    [No Abstract]   [Full Text] [Related]  

  • 31. [Aetiological and clinical study on subacute myelo-optico-neuropathy (SMON) (author's transl)].
    Tsubaki T
    Nihon Naika Gakkai Zasshi; 1974 Jan; 63(1):1-17. PubMed ID: 4856733
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ocular disorders in SMON (subacute myelo-optico neuropathy), especially neuro-retinal lesions].
    Okuda K; Matsuo H; Ueno H
    Nippon Ganka Gakkai Zasshi; 1971; 75(8):1937-43. PubMed ID: 5165911
    [No Abstract]   [Full Text] [Related]  

  • 33. [Subacute myelo-optic neuropathy--toxic reaction or viral disease?].
    Dimov D
    Lijec Vjesn; 1972 Jul; 94(7):363-6. PubMed ID: 4266549
    [No Abstract]   [Full Text] [Related]  

  • 34. [Neurotoxicity of chinoform].
    Iwashita H
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):602-5. PubMed ID: 10434730
    [No Abstract]   [Full Text] [Related]  

  • 35. Introductory review of subacute myeolo-optico-neuropathy (SMON) and its studies done by the SMON Research Commission.
    Kono R
    Jpn J Med Sci Biol; 1975; 28 Suppl():1-21. PubMed ID: 136534
    [No Abstract]   [Full Text] [Related]  

  • 36. Subacute myelo-optic neuropathy is not a special form of multiple sclerosis.
    Kono R; Kuroiwa Y
    Lancet; 1982 Jul; 2(8292):267. PubMed ID: 6124690
    [No Abstract]   [Full Text] [Related]  

  • 37. [Letter: Subacute myelopathy following hydroxyquinoleine absorption].
    Laterre EC; Stevens A; Goffin L; Velghe L
    Nouv Presse Med; 1973 Oct; 2(38):2550. PubMed ID: 4763459
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical cases of subacut myelo-optico-neuropathy(SMON) accompanied with abdominal symptoms].
    Takasaki H; Kanamaru M
    Naika; 1970 Mar; 25(3):477-83. PubMed ID: 5444906
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experimental studies of influence of hepatic insufficiency on pathogenesis of S.M.O.N. (subacute myelo-optico neuropathy) caused by chinoform administration in dogs (author's transl)].
    Hayakawa K
    Hokkaido Igaku Zasshi; 1974 May; 49(3):213-23. PubMed ID: 4281757
    [No Abstract]   [Full Text] [Related]  

  • 40. Subacute myelo-optic neuropathy and the halogenated hydroxyquinolines.
    Med J Aust; 1971 Nov; 2(21):1090-1. PubMed ID: 5127493
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.